Datavant, the leader in helping healthcare organizations safely connect their data, announced a strategic partnership with Seqster, the award-winning SaaS-based healthcare technology company enabling patient-centric interoperability. In this partnership, Datavant’s privacy-preserving linking technology will be integrated within Seqster’s patient-centric interoperability platform. For the first time, real-time medical records, wearables, and genomics data could be connected with other health data sources to create a live 360° view of the patient.
Recommended AI News: eTeacher Group Strengthens Partnership With Nuvei With Launch of Langaroo.com
Seqster’s first-of-its-kind platform enables life science companies and CROs to automatically retrieve patient data directly from a patients’ EHR record for the clinical trial process. With this new partnership, Seqster will also have the ability to match real-world data from Datavant’s open data ecosystem to their existing patient-level data collected through the Seqster platform. The new combined solution gives life sciences customers an off-the-shelf system to seamlessly process and analyze a patient’s longitudinal health journey, leading to a better understanding of patient outcomes, therapy efficacy, and value-based healthcare.
Recommended AI News: Polygon.io Announces $6 Million Series A to Fuel the Expansion of Its Financial Data Platform
“Integrating real-world data into clinical trials enables sponsors to accelerate the clinical and commercial development process, increasing the speed of therapies to market. Seqster has an innovative solution that utilizes patient data already captured in EHRs to fill important data gaps,” said Travis May, Chief Executive Officer at Datavant. “We are living through a fundamental transformation in the use of RWD, and we firmly believe that the effective use of real-world data can help better understand the safety and efficacy of drugs that are brought to market.”
“We are excited to enter into this partnership to continue providing innovative ways for life sciences companies to better understand the patients participating in their trials, said Ardy Arianpour, Chief Executive Officer & Co-Founder at Seqster. “The combination of Seqster’s FDA-compliant platform and Datavant’s privacy-protecting linking technology provides a vital data super-highway that is secure, private, and readily accessible for pharmaceutical companies and the broader healthcare ecosystem.”
Recommended AI News: Quest Analytics Expands Leadership Team with the Addition of Barbara Dumery as Chief Product Officer
Scrap copper waste disposal Electrolytic copper refining Metal waste repurposing technologies
Copper cable export documentation, Metal scraps reclamation, Scrap Copper recovery
Scrap metal processing technology Ferrous metal scrap solutions Iron waste disposal facility
Ferrous material recycling handling, Iron scraps reprocessing, Scrap metal environmental impact